This poster was presented at the 29th Annual U.S. Psychiatric & Mental Health Congress, held October 21-24, 2016, in San Antonio, Texas.
Objectives: To examine the frequency and severity of inadequate attention-deficit/hyperactivity disorder (ADHD) symptom control and related early morning functioning (EMF) impairments in stimulant-treated children/adolescents, and their impact on caregivers.
Methods: Two quantitative research surveys (Study 1 [S1] and 2 [S2]) were conducted. Inclusion criteria were identical: participants were primary caregivers of children/adolescents (6-17 years) with ADHD currently taking a stimulant as their primary ADHD medication at a stable dose for ≥3 months prior to the survey. In both surveys, caregivers that rated their child's ADHD symptoms during the early morning routine (EMR), defined as the moment the child/adolescent awakens until departure for school, as ≥2 on a 10-point Likert scale-with 1 denoting "mild" and 10 "severe"-continued the survey.
Results: There were 201 and 300 completed surveys in S1 and S2, respectively. The severity of EMF impairments was rated as 6.1 in S1 and 6.2 in S2. In both studies, the majority of caregivers reported early morning ADHD symptoms (S1, 74%; S2, 87%) and EMF impairment (S1, 76%; S2, 77%) as moderate-to-severe (Likert score 5-10). As a result of their child's ADHD symptoms during the EMR, caregivers reported that they often or sometimes "felt overwhelmed and exhausted" (S1, 79%; S2, 75%), "raised their voice more" (S1, 81%; S2, 78%), and "felt constantly stressed" (S1, 77%; S2, 70%).
Conclusions: In 2 quantitative research surveys, primary caregivers reported a concordantly high prevalence and severity of EMF impairment in their stimulant-treated children/adolescents with ADHD, which had a negative emotional impact on caregivers.